Femtosecond Laser-Assisted Keratoplasty (FLAK)

January 16, 2015 updated by: Shahzad Mian, University of Michigan
The purpose of this study will be to determine optimal surgical technique for performing FLAK including laser parameters, keratoplasty shape and suture technique in order to standardize surgical technique and to collect safety and efficacy data. This will be compared to data of patients with full thickness PKP to measure visual outcomes, refraction, astigmatism, surgical methods and wound healing.

Study Overview

Status

Completed

Conditions

Detailed Description

FLAK Instrument: The Femtosecond Laser (IntraLase Corporation, Irvine, CA) is a focusable infrared laser, similar to the more familiar neodymium-yttrium-aluminum-garnet (YAG) laser, but uses shorter pulses in the hundred-femtosecond (100 X 10-15 seconds) duration range. There is minimal postoperative inflammation and collateral tissue damage.

Subjects: We will be enrolling subjects 18 years or older that need keratoplasty based on clinical findings. Subjects will be enrolled regardless of race or gender on a first come first serve basis. Subjects will be recruited from the physicians own clinic.

PKP Subjects: We will do a retrospective chart review on subjects who have undergone traditional PKP. FLAK eyes will be age and gender matched to these PKP eyes to compare visual outcomes, wound healing and complications.

Study Type

Observational

Enrollment (Actual)

24

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

subjects indicated for corneal transplant surgery

Description

Inclusion Criteria:

  1. Corneal opacification.
  2. Reduced ETDRS-measured, best corrected, distance visual acuity to 20/40 or worse.
  3. Ability to participate in follow-up visits..

Exclusion Criteria:

  1. Corneal opacification adequately dense to obscure visualization of iris.
  2. ETDRS-measured, best-corrected, distance visual acuity of 20/30 or better.
  3. Corneal thickness greater than 1200 µm at the 9 mm peripheral zone.
  4. Severe corneal thinning including descemetocoele with impending corneal rupture.
  5. Prior PKP or incisional surgery that may provide a potential space into which the gas produced by the procedure can escape.
  6. Poor visual potential in the non-study eye (VA of 20/100 or less, without potential for improvement by the examining ophthalmologist's judgment).
  7. History of glaucoma, including steroid response rise in intraocular pressure.
  8. Active intraocular inflammation or infection.
  9. Age 18 or younger (consideration will be given to an upper age limit).
  10. Unable to return for scheduled follow-up examinations.
  11. Other medical condition(s) that will likely prevent long term follow-up.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
FLAK
PKP
Retrospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Surgical outcomes
Time Frame: 1 day, 1 week, 1, 3, 6, 12, 18 and 24 months
Wound healing, surgical complications, visual function and endothelial layer assessment
1 day, 1 week, 1, 3, 6, 12, 18 and 24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2007

Primary Completion (Actual)

March 1, 2012

Study Completion (Actual)

December 1, 2013

Study Registration Dates

First Submitted

September 27, 2012

First Submitted That Met QC Criteria

September 27, 2012

First Posted (Estimate)

September 28, 2012

Study Record Updates

Last Update Posted (Estimate)

January 21, 2015

Last Update Submitted That Met QC Criteria

January 16, 2015

Last Verified

January 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • FLAK-15615

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Keratoconus

3
Subscribe